Does combination therapy with vancomycin and piperacillin-tazobactam increase the risk of nephrotoxicity versus vancomycin alone in pediatric patients?

Journal of Pediatric Pharmacology and Therapeutics

Volumn 21, Issue 4, 2016, Pages 332-338

  McQueen, Katherine E ^a   Clark, Dana W ^a  

^a Children’s Healthcare of Atlanta ^*  (United States)

Author keywords

Acute kidney injury; Adverse drug effect; Nephrotoxicity; Pediatric; Piperacillin tazobactam; Vancomycin

Indexed keywords

EID: 85018188055     PISSN: 15516776     EISSN: 2331348X     Source Type: Journal    
DOI: 10.5863/1551-6776-21.4.332     Document Type: Article

References (10)

1. McKamy S, Hernandez E, Jahng M, et al. Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children. J Pediatr. 2011;158(3):422-426.
2. Burgess LD, Drew RH. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam. Pharmacotherapy. 2014;34(7):670-676.
3. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Disease Pharmacists. Am J Health Syst Pharm. 2009;66(1):82-98.
4. Hazlewood KA, Brouse SD, Pitcher WD, et al. Vancomycin-associated nephrotoxicity: grave concern or death by character assassination? Am J Med. 2010;123(2):182.e1-182.e7.
5. Zosyn [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals Inc; 2011.
6. O’Rourke K. Vancomycin plus piperacillintazo may trigger acute kidney injury. Pharm Pract News. 2012;39. http://www.pharmacypracticenews.com/ViewArticle.aspx?d=Clinical&d_id=50&i=June+2012&i_id=853&a_id=20974. Accessed July 19, 2016.
7. Gomes DM, Smotherman C, Birch A, et al. Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin-tazobactam or cefepime. Pharmacotherapy. 2014;34(7):662-669.
8. Pratt JA, Stricherz MK, Verghese PS, Burke MJ. Suspected piperacillin-tazobactam induced nephrotoxicity in the pediatric oncology population. Pediatr Blood Cancer. 2014;61(2):366-368.
9. Buck ML. Vancomycin-associated nephrotoxicity and the use of higher trough concentrations in infants and children. Pediatr Pharm. 2014;20(10).
10. Jeffres MN, Isakow W, Doherty JA, et al. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther. 2007;29(6):1107-1115.